Professor, Surgery, University of Kentucky College of Medicine
Urology
Dr. Deborah R. Erickson, MD
|
|
Give Review
Doctor Deborah R. Erickson, MD is an expert in the field of Urology. She attended University of Missouri-Columbia School of Medicine. She has 2 awards "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Deborah Erickson is a published doctor and has 53 publications published. The lastest was: 'In vitro ligation of ureters and urethra modulates fetal mouse bladder explants development.' She accepts all Medicare patients.
Publications
- Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment.
- Diagnosis and treatment of arterial-ureteric fistula.
- Cyclosporine A for refractory interstitial cystitis/Bladder pain syndrome: experience of 3 tertiary centers.
- Management of interstitial cystitis/Bladder pain syndrome: a urology perspective.
- Practical Use of the New American Urological Association Interstitial Cystitis Guidelines.
- Identifying Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome.
- Early Adoption of New Devices: Flying on Untested Wings.
- Gene Expression Analysis of Urine Sediment: Evaluation for Potential Noninvasive Markers of Interstitial Cystitis/Bladder Pain Syndrome.
- Safety and errors: a lesson from the airlines.
- Patient safety: above and beyond the checklist.
- Are urodynamics needed before surgery for straightforward female stress Incontinence?
- Menopausal hormone therapy--why do different studies have different results for the same outcome?
- The placebo response.
- Differentiation associated changes in gene expression profiles of Interstitial cystitis and control urothelial cells.
- The use of mesh for Pelvic reconstruction--how much, what type and where?
- Urine markers do not predict biopsy findings or presence of Bladder ulcers in interstitial cystitis/painful Bladder syndrome.
- Learning objectives.
- Changes in urine markers and symptoms after Bladder distention for interstitial cystitis.
- Pregnancy and interstitial cystitis/painful Bladder syndrome.
- Molecular size affects Urine excretion of pentosan polysulfate.
- Enhanced binding of modified pentosan polysulfate and heparin to Bladder--a strategy for improved treatment of interstitial cystitis.
- Hormone replacement therapy: the right choice for your patient?
- Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cysti...
- Is Urine methylhistamine a useful marker for interstitial cystitis?
- Comparison of APF activity and epithelial growth factor levels in Urine from Chinese, African-American, and white American patients with interstitial cystitis.
- A comparison of multiple Urine markers for interstitial cystitis.
- Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as Urine markers for i...
- Increased urinary hyaluronic acid and Interstitial cystitis.
- Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in Interstitial cystitis.
- NonBladder related symptoms in patients with interstitial cystitis.
- Urine markers of interstitial cystitis.
- An investigation of the nature of Bladder mucosal glycoconjugates and their role in interstitial cystitis.
- A new direct test of Bladder permeability.
- Relationships between Bladder inflammation and other clinical features in interstitial cystitis.
- Urinary epitectin (MUC-1 glycoprotein) in the menstrual cycle and Interstitial cystitis.
- The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics.
- Inflammatory cell types and clinical features of Interstitial cystitis.
- Re: an interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in Bladder carcinoma.
- Characterization of the rabbit homolog of human MUC1 glycoprotein isolated from Bladder by affinity chromatography on immobilized jacalin.
- Quantitation of Urinary glycosaminoglycans with Alcian blue: evaluation of the interference by Tamm-Horsfall glycoprotein.
- AUA Guideline for the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
- Urethral Obstruction after anterior colporrhaphy: correction by simple vaginoplasty.
- Interstitial cystitis: update on etiologies and therapeutic options.
- Glomerulations in women with Urethral sphincter deficiency: report of 2 cases [corrected].
- Female stress Incontinence.
- Characterization and immunohistochemical localization of the glycoconjugates of the rabbit Bladder mucosa.
- An unusual complication of ureteroscopy with general anaesthesia: cauda equina syndrome.
- Transitional cell Bladder carcinoma with presentation mimicking ovarian carcinoma.
- In vitro ligation of ureters and urethra modulates fetal mouse Bladder explants development.
- Can direct pay improve the shortage of primary care in the United States?
- Prostatic acid phosphatase, beta-glucuronidase and Prostate specific antigen assays in fine needle aspirates from benign and malignant Prostates.
- A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
Schools
UNIV OF MO COLUMBIA SCH OF MED
University Tex
University Of California Los Angeles
Procedures Preformed
- Cystectomy
- Cystometry
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Incontinence Sling Procedure
- View All
Conditions Treated
- Atrophic Vaginitis
- Bedwetting
- Bladder Cancer
- Bladder Infection
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Texas Health Science Center -
University of Missouri-Columbia School of Medicine
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1619930468 | |
| NPPES Provider LastName | ERICKSON | |
| NPPES Provider FirstName | DEBORAH | |
| NPPES Provider ZIPCode | 405360001 | |
| NPPES Provider State | KY | |
| Specialty Description | Urology | |
| Total Claim Count | 612.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619930468 |
| Last Name Of The Provider | ERICKSON |
| First Name Of The Provider | DEBORAH |
| View All |
Similar Doctors
|
|
Dr. Jonathan P. Walker, MD |
|
|
Dr. Terrence R. Grimm, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas K. Slabaugh Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Lacy, MD |
|
Dr. William R. Allen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew C. McGregor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel W. Belknap, MD |
|
Dr. Shubham Gupta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suvas G. Desai, MD
This Doctor is OpenDoctor Recommended.
|